Latest filing published 27 Aug 2026 for UFP Technologies INC, €951k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Marc d. Kozin span 5 companies, the busiest being UFP Technologies Inc, Dyax Corp and Dicerna Pharmaceuticals Inc. We count 18 filings; the first trade dates from 31 December 2015 and the latest from 25 August 2026.
Market trades split into 1 purchase (€61k) and 2 sales (€1.8M). Sales outweigh purchases by €1.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 6 share grants and 4 option exercises. 2026 to date brings no purchases and 2 sales.
On 27 August 2026 came the latest disclosure, an open-market sale for €951k in UFP Technologies Inc. The last insider purchase was made public on 10 August 2021, 1,895 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations